Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177.

TitleHemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177.
Publication TypeJournal Article
Year of Publication2010
AuthorsCramer YS, Rosenkranz SL, Hall SD, Szczech LA, Amorosa V, Gupta SK
JournalJ Acquir Immune Defic Syndr
Volume54
Issue4
Paginatione7-9
Date Published2010 Aug
ISSN1944-7884
KeywordsAcquired Immunodeficiency Syndrome, Anti-HIV Agents, Combined Modality Therapy, HIV Infections, HIV-1, Nevirapine, Renal Dialysis
DOI10.1097/QAI.0b013e3181e2d5e5
Alternate JournalJ. Acquir. Immune Defic. Syndr.
PubMed ID20611034
PubMed Central IDPMC2912759
Grant List1U01AI068634-01 / AI / NIAID NIH HHS / United States
A168636 / / PHS HHS / United States
AI69467 / AI / NIAID NIH HHS / United States
U01 AI032783 / AI / NIAID NIH HHS / United States
U01 AI032783-12 / AI / NIAID NIH HHS / United States
U01 AI068634 / AI / NIAID NIH HHS / United States
U01 AI068634-01 / AI / NIAID NIH HHS / United States
U01 AI068636 / AI / NIAID NIH HHS / United States
U01 AI068636-01 / AI / NIAID NIH HHS / United States
UL1 RR024134 / RR / NCRR NIH HHS / United States
UL1 RR024134-010001 / RR / NCRR NIH HHS / United States
UL1RR024134 / RR / NCRR NIH HHS / United States